Clinical trial
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 · Ottawa Hospital Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00261014 |
|---|---|
| Title | Understanding Risk Factors Involved in Developing a Second Blood Clot. |
| Official title | REcurrent VEnous Thromboembolism Risk Stratification Evaluation A Study to Develop a Clinical Prediction Rule to Predict Low Recurrence Risk in Patients With Idiopathic Venous Thromboembolism. |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Biomerieux inc Industry Heart and Stroke Foundation of Ontario |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Deep Vein Thrombosis |
| Enrollment | 800 |
| Start date | Oct 1, 2002 |
| Primary completion | Mar 1, 2016 |
| Completion | Mar 1, 2016 |
| First posted | Dec 2, 2005 |
| Last update posted | Nov 18, 2015 |
| Countries | Canada, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: